Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1995 Feb;50(2):134–138. doi: 10.1136/thx.50.2.134

Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.

A Grove 1, L C McFarlane 1, B J Lipworth 1
PMCID: PMC473898  PMID: 7701450

Abstract

BACKGROUND--Salbutamol exhibits partial agonist/antagonist activity at airway beta 2 receptors in vitro in that it attenuates the bronchorelaxant effect of the full agonist isoprenaline. The aim of the present study was to characterise the partial beta 2 agonist/antagonist activity of salbutamol in vivo during supine rest and exercise, in states of low and high adrenergic tone. METHODS--Eight normal subjects were randomised to receive single oral doses of salbutamol 2 mg, 4 mg, 8 mg (S2, S4, S8), placebo (PL), or propranolol 80 mg (PR). The beta 2 adrenoceptor responses were evaluated after supine rest and subsequently in response to maximal exercise. RESULTS--Salbutamol demonstrated a dose-related increase in resting heart rate and tremor and a fall in serum potassium level consistent with beta 2 agonism. On exercise, the hyperkalaemic response was augmented by propranolol compared with placebo consistent with beta 2 blockade: mean difference for delta response (95% CI) PR v PL was 0.60 (0.02 to 1.27) mmol/l. This effect also occurred with salbutamol in a dose-related fashion: S8 v PL 0.33 (0.01 to 0.71) mmol/l, S8 v S2 0.31 (-0.02 to 0.61) mmol/l. Whilst propranolol blunted exercise heart rate in keeping with beta 1 blockade, salbutamol had no effect. Exercise produced an increase in lymphocyte beta 2 receptor binding density (Bmax) which was not affected by salbutamol. Plasma levels of adrenaline and noradrenaline at peak exercise were also unaltered by salbutamol in comparison with placebo. CONCLUSIONS--In a state of low adrenergic tone at rest salbutamol produces effects consistent with beta 2 agonism. In contrast, in a state of increased adrenergic tone during exercise salbutamol produced beta 2 selective antagonism as evidenced by its effects on exercise-induced hyperkalaemia (beta 2) but not on exercise-induced tachycardia (beta 1). The effects of salbutamol on beta 2 receptor density do not explain its effects on exercise-induced hyperkalaemia since upregulation rather than downregulation was observed. This in vivo phenomenon of partial beta 2 agonist/antagonist activity of salbutamol may be of relevance in the setting of acute asthma if adrenergic tone is increased.

Full text

PDF
134

Images in this article

136Image
on p.136
136Image
on p.136

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aon M., Thomas D., Hervagault J. F. Spatial patterns in a photobiochemical system. Proc Natl Acad Sci U S A. 1989 Jan;86(2):516–519. doi: 10.1073/pnas.86.2.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold J. M., O'Connor P. C., Riddell J. G., Harron D. W., Shanks R. G., McDevitt D. G. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man. Br J Clin Pharmacol. 1985 May;19(5):619–630. doi: 10.1111/j.1365-2125.1985.tb02689.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brodde O. E., Daul A. E., Wang X. L., Michel M. C., Galal O. Dynamic exercise-induced increase in lymphocyte beta-2-adrenoceptors: abnormality in essential hypertension and its correction by antihypertensives. Clin Pharmacol Ther. 1987 Apr;41(4):371–379. doi: 10.1038/clpt.1987.43. [DOI] [PubMed] [Google Scholar]
  4. Brown M. J., Jenner D. A. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity. Clin Sci (Lond) 1981 Nov;61(5):591–598. doi: 10.1042/cs0610591. [DOI] [PubMed] [Google Scholar]
  5. Butler J., Kelly J. G., O'Malley K., Pidgeon F. Beta-adrenoceptor adaptation to acute exercise. J Physiol. 1983 Nov;344:113–117. doi: 10.1113/jphysiol.1983.sp014927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Graafsma S. J., van Tits L. J., van Heijst P., Reyenga J., Lenders J. W., Rodrigues de Miranda J. F., Thien T. Adrenoceptors on blood cells in patients with essential hypertension before and after mental stress. J Hypertens. 1989 Jul;7(7):519–524. doi: 10.1097/00004872-198907000-00002. [DOI] [PubMed] [Google Scholar]
  7. Lindén A., Bergendal A., Ullman A., Skoogh B. E., Löfdahl C. G. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax. 1993 May;48(5):547–553. doi: 10.1136/thx.48.5.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lipworth B. J., McDevitt D. G. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol. 1989;36(3):239–245. doi: 10.1007/BF00558154. [DOI] [PubMed] [Google Scholar]
  9. Maisel A. S., Harris T., Rearden C. A., Michel M. C. Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation. 1990 Dec;82(6):2003–2010. doi: 10.1161/01.cir.82.6.2003. [DOI] [PubMed] [Google Scholar]
  10. Maisel A. S., Knowlton K. U., Fowler P., Rearden A., Ziegler M. G., Motulsky H. J., Insel P. A., Michel M. C. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Invest. 1990 Feb;85(2):462–467. doi: 10.1172/JCI114460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Murray D. R., Irwin M., Rearden C. A., Ziegler M., Motulsky H., Maisel A. S. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-dependent mechanism. Circulation. 1992 Jul;86(1):203–213. doi: 10.1161/01.cir.86.1.203. [DOI] [PubMed] [Google Scholar]
  12. Newnham D. M., Coutie W. J., McFarlane L. C., Lipworth B. J. Comparison of parameters of in vitro lymphocyte beta 2-adrenoceptor function in normal and asthmatic subjects. Eur J Clin Pharmacol. 1993;45(6):535–538. doi: 10.1007/BF00315310. [DOI] [PubMed] [Google Scholar]
  13. Nørgaard A., Bøtker H. E., Klitgaard N. A., Toft P. Digitalis enhances exercise-induced hyperkalaemia. Eur J Clin Pharmacol. 1991;41(6):609–611. doi: 10.1007/BF00314994. [DOI] [PubMed] [Google Scholar]
  14. O'Donnell S. R. An examination of some -adrenoreceptor stimulants for selectivity using the isolated trachea and atria of the guinea pig. Eur J Pharmacol. 1972 Sep;19(3):371–379. doi: 10.1016/0014-2999(72)90104-5. [DOI] [PubMed] [Google Scholar]
  15. O'Donnell S. R., Wanstall J. C. Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on beta-adrenoceptors in guinea-pig trachea. Eur J Pharmacol. 1978 Feb 1;47(3):333–340. doi: 10.1016/0014-2999(78)90241-8. [DOI] [PubMed] [Google Scholar]
  16. Pringle T. H., Riddell J. G., Shanks R. G. Characterization of the beta-adrenoreceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man. Eur J Clin Pharmacol. 1988;35(5):507–514. doi: 10.1007/BF00558246. [DOI] [PubMed] [Google Scholar]
  17. Struthers A. D., Quigley C., Brown M. J. Rapid changes in plasma potassium during a game of squash. Clin Sci (Lond) 1988 Apr;74(4):397–401. doi: 10.1042/cs0740397. [DOI] [PubMed] [Google Scholar]
  18. Tohmeh J. F., Cryer P. E. Biphasic adrenergic modulation of beta-adrenergic receptors in man. Agonist-induced early increment and late decrement in beta-adrenergic receptor number. J Clin Invest. 1980 Apr;65(4):836–840. doi: 10.1172/JCI109735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wagner J., Reinhardt D., Schümann H. J. Comparison of the bronchodilator and cardiovascular actions of isoprenaline, Th 1165a, terbutaline and salbutamol in cats and isolated organ preparations. Res Exp Med (Berl) 1974;162(1):49–62. doi: 10.1007/BF01851883. [DOI] [PubMed] [Google Scholar]
  20. Waller D. G. Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy? Br J Clin Pharmacol. 1990 Aug;30(2):157–171. doi: 10.1111/j.1365-2125.1990.tb03760.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wheeldon N. M., McDevitt D. G., Lipworth B. J. Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man. Br J Clin Pharmacol. 1994 Apr;37(4):363–369. doi: 10.1111/j.1365-2125.1994.tb04290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Williams M. E., Gervino E. V., Rosa R. M., Landsberg L., Young J. B., Silva P., Epstein F. H. Catecholamine modulation of rapid potassium shifts during exercise. N Engl J Med. 1985 Mar 28;312(13):823–827. doi: 10.1056/NEJM198503283121304. [DOI] [PubMed] [Google Scholar]
  23. Wilson C., Lincoln C. Beta-adrenoceptor subtypes in human, rat, guinea pig, and rabbit atria. J Cardiovasc Pharmacol. 1984 Nov-Dec;6(6):1216–1221. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES